Evidence map›Paper›PMID 37835382›Full record

ArticleCancers2023

Genetic Variants as Predictors of the Success of Colorectal Cancer Treatments.

Koldo Garcia-Etxebarria, Ane Etxart, Maialen Barrero, Beatriz Nafria, Nerea Miren Segues Merino, Irati Romero-Garmendia, Ajay Goel, Andre Franke, Mauro D'Amato, Luis Bujanda

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Koldo Garcia-EtxebarriaBiodonostia, Gastrointestinal Genetics Group, 20014 San Sebastián, Spain.ORCID 0000-0002-6107-9416
Ane EtxartBiodonostia, Gastrointestinal Disease Group, Universidad del País Vasco (UPV/EHU), 20014 San Sebastián, Spain.ORCID 0000-0001-6598-2402
Maialen BarreroBiodonostia, Gastrointestinal Disease Group, Universidad del País Vasco (UPV/EHU), 20014 San Sebastián, Spain.
Beatriz NafriaBiodonostia, Gastrointestinal Disease Group, Universidad del País Vasco (UPV/EHU), 20014 San Sebastián, Spain.ORCID 0000-0002-4698-5680
Nerea Miren Segues MerinoBiodonostia, Gastrointestinal Disease Group, Universidad del País Vasco (UPV/EHU), 20014 San Sebastián, Spain.
Irati Romero-GarmendiaDepartment of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (Universidad del País Vasco/Euskal Herriko Unibertsitatea), 48940 Leioa, Spain.
Ajay GoelDepartment of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.ORCID 0000-0003-1396-6341
Andre FrankeInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, 24105 Kiel, Germany.
Mauro D'AmatoGastrointestinal Genetics Lab, CIC bioGUNE, Basque Research and Technology Alliance, 48160 Derio, Spain.ORCID 0000-0003-2743-5197
Luis BujandaCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 08036 Barcelona, Spain.
University of the Basque Country · ESBiogipuzkoa Health Research Institute · ESChristian-Albrechts-Universität zu Kiel · DECity of Hope · USIkerbasque · ES

Funding

Diputación Foral de Gipuzkoa 111/17
6 · The paper itself

Abstract

backgroundSome genetic polymorphisms (SNPs) have been proposed as predictors for different colorectal cancer (CRC) outcomes. This work aims to assess their performance in our cohort and find new SNPs associated with them.

methodsA total of 833 CRC cases were analyzed for seven outcomes, including the use of chemotherapy, and stratified by tumor location and stage. The performance of 63 SNPs was assessed using a generalized linear model and area under the receiver operating characteristic curve, and local SNPs were detected using logistic regressions.

resultsIn total 26 of the SNPs showed an AUC > 0.6 and a significant association (

conclusionsSome SNPs with clinical data can be used in our population as predictors of some CRC outcomes, and the local SNPs detected in our study could be feasible markers that need further validation as predictors.

Indexed as

colorectal cancergenetic associationgeneticsmarkersoutcomessurvivaltreatment

Identifiers

PMID37835382
PMCPMC10571592
OpenAlexW4386995999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.